Chemung Canal Trust’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$650K Sell
8,314
-42,643
-84% -$3.44M 0.12% 85
2026
Q1
$4.42M Sell
50,957
-16,261
-24% -$1.56M 0.89% 34
2025
Q4
$6.46M Buy
67,218
+845
+1% +$82.1K 1.28% 26
2025
Q3
$6.32M Buy
66,373
+851
+1% +$78.2K 1.26% 27
2025
Q2
$5.71M Buy
65,522
+17,762
+37% +$1.51M 1.2% 28
2025
Q1
$4.29M Buy
47,760
+14,468
+43% +$1.29M 0.94% 33
2024
Q4
$2.66M Sell
33,292
-5,439
-14% -$471K 0.55% 50
2024
Q3
$3.49M Sell
38,731
-11,157
-22% -$939K 0.71% 46
2024
Q2
$3.93M Buy
49,888
+1,986
+4% +$163K 0.76% 46
2024
Q1
$4.17M Buy
47,902
+44,846
+1,467% +$3.83M 0.81% 43
2023
Q4
$252K Sell
3,056
-47,866
-94% -$3.65M 0.05% 111
2023
Q3
$3.99M Buy
50,922
+7,949
+18% +$665K 0.92% 35
2023
Q2
$3.79M Buy
42,973
+30,729
+251% +$2.65M 0.81% 40
2023
Q1
$987K Sell
12,244
-3,679
-23% -$300K 0.23% 73
2022
Q4
$1.24M Sell
15,923
-52,274
-77% -$4.24M 0.28% 68
2022
Q3
$5.51M Sell
68,197
-298
-0.4% -$26.8K 1.37% 26
2022
Q2
$6.15M Buy
68,495
+46,056
+205% +$4.67M 1.4% 23
2022
Q1
$2.49M Sell
22,439
-13,416
-37% -$1.42M 0.48% 57
2021
Q4
$3.71M Sell
35,855
-60,912
-63% -$7.05M 0.67% 52
2021
Q3
$12.1M Buy
96,767
+2,089
+2% +$270K 2.33% 7
2021
Q2
$11.8M Sell
94,678
-2,122
-2% -$266K 2.25% 9
2021
Q1
$11.4M Buy
96,800
+19,872
+26% +$2.33M 2.29% 9
2020
Q4
$9.01M Buy
76,928
+7,555
+11% +$832K 1.89% 14
2020
Q3
$7.21M Buy
69,373
+300
+0.4% +$30.1K 1.72% 16
2020
Q2
$6.33M Sell
69,073
-167
-0.2% -$16K 1.65% 17
2020
Q1
$6.24M Sell
69,240
-1,108
-2% -$118K 1.91% 16
2019
Q4
$7.98M Sell
70,348
-2,084
-3% -$229K 1.81% 17
2019
Q3
$7.87M Buy
72,432
+7,230
+11% +$754K 1.92% 15
2019
Q2
$6.35M Sell
65,202
-20,090
-24% -$1.83M 1.48% 27
2019
Q1
$7.77M Buy
85,292
+1,351
+2% +$121K 1.85% 19
2018
Q4
$7.64M Buy
83,941
+11,326
+16% +$1.06M 2.19% 12
2018
Q3
$7.14M Buy
72,615
+29,427
+68% +$2.72M 1.58% 23
2018
Q2
$3.7M Buy
43,188
+10,950
+34% +$915K 0.89% 37
2018
Q1
$2.59M Buy
32,238
+18,791
+140% +$1.55M 0.62% 50
2017
Q4
$1.08M Buy
13,447
+9,763
+265% +$782K 0.24% 73
2017
Q3
$286K Buy
+3,684
New +$306K 0.07% 103
2015
Q4
Sell
-4,106
Closed -$275K 134
2015
Q3
$275K Sell
4,106
-1,200
-23% -$88.4K 0.07% 117
2015
Q2
$393K Hold
5,306
0.09% 115
2015
Q1
$414K Buy
5,306
+520
+11% +$39.4K 0.08% 114
2014
Q4
$346K Buy
4,786
+130
+3% +$9.03K 0.07% 120
2014
Q3
$288K Buy
4,656
+20
+0.4% +$1.27K 0.06% 122
2014
Q2
$296K Hold
4,636
0.06% 127
2014
Q1
$285K Hold
4,636
0.06% 126
2013
Q4
$266K Hold
4,636
0.06% 127
2013
Q3
$247K Buy
+4,636
New +$249K 0.05% 124

Other funds holding MDT

Chemung Canal Trust's MDT Position: Q2 2026 in Review

Chemung Canal Trust reduced its Medtronic (MDT) stake by 84% in Q2 2026, selling an estimated $3.44M and leaving 8,314 shares worth $650K. The position accounts for 0.12% of the portfolio, ranked #85.

Chemung Canal Trust first reported a position in MDT in Q3 2013 and has held it in 45 quarters since. The position peaked at $12.1M in Q3 2021. 493 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Chemung Canal Trust held 8,314 shares of Medtronic worth $650K as of Q2 2026.
  • Chemung Canal Trust sold 42,643 Medtronic shares in Q2 2026, an estimated $3.44M.
  • Medtronic made up 0.12% of Chemung Canal Trust's portfolio in Q2 2026, its #85 holding.
  • Chemung Canal Trust first reported a position in Medtronic in Q3 2013 and has held it in 45 quarters since.
  • Chemung Canal Trust's Medtronic position peaked at $12.1M in Q3 2021.
  • 493 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Chemung Canal Trust's 13F filing for Q2 2026, filed 15 Jul 2026.